TY - JOUR
T1 - Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy
T2 - Results of Phase I of the PRECINCT Study in 707 Patients
AU - Bhatt, Aditi
AU - Villeneuve, Laurent
AU - Sardi, Armando
AU - Souadka, Amine
AU - Buseck, Alison
AU - Moran, Brendan J.
AU - Khannousi, Basma El
AU - de Pedro, Carlos Gonzalez
AU - Baratti, Dario
AU - Biacchi, Danielle
AU - Morris, David
AU - Labow, Daniel
AU - Levine, Edward A.
AU - Mohamed, Faheez
AU - Adeleke, Gbadebo
AU - Goswami, Gaurav
AU - Bonnefoy, Isabelle
AU - Perry, Katherine Cummins
AU - Votanopoulos, Konstantinos I.
AU - Parikh, Loma
AU - Deraco, Marcello
AU - Alyami, Mohammad
AU - Cohen, Noah
AU - Benzerdjeb, Nazim
AU - Shah, Nehal
AU - Bahaoui, Nezha El
AU - Khajoueinejad, Nazanin
AU - Rousset, Pascal
AU - Shen, Perry
AU - Barat, Shoma
AU - Stanford, Sophia
AU - Khouchoua, Selma
AU - Troob, Samantha
AU - Shaikh, Sakina
AU - Sarpel, Umut
AU - Gushchin, Vadim
AU - Samuel, Vasanth Mark
AU - Kepenekian, Vahan
AU - Sammartino, Paolo
AU - Glehen, Olivier
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Background: The PRECINCT (Pattern of peritoneal dissemination and REsponse to systemic Chemotherapy IN Common and uncommon peritoneal Tumors) is a prospective, multicenter, observational study. This report from phase I of PRECINCT outlines variations in recording the surgical peritoneal cancer index (sPCI) at experienced peritoneal malignancy centers and the incidence of pathologically confirmed disease in morphologically different peritoneal lesions (PL). Methods: The sPCI was recorded in a prespecified format that included the morphological appearance of PL. Six prespecified morphological terms were provided. The surgical and pathological findings were compared. Results: From September 2020 to December 2021, 707 patients were enrolled at 10 centers. The morphological details are routinely recorded at two centers, structure bearing the largest nodule, and exact size of the largest tumor deposit in each region at four centers each. The most common morphological terms used were normal peritoneum in 3091 (45.3%), tumor nodules in 2607 (38.2%) and confluent disease in 786 (11.5%) regions. The incidence of pathologically confirmed disease was significantly higher in ‘tumor nodules’ with a lesion score of 2/3 compared with a lesion score of 1 (63.1% vs. 31.5%; p < 0.001). In patients receiving neoadjuvant chemotherapy, the incidence of pathologically confirmed disease did not differ significantly from those undergoing upfront surgery [751 (47.7%) and 532 (51.4%) respectively; p = 0.069]. Conclusions: The sPCI was recorded with heterogeneity at different centers. The incidence of pathologically confirmed disease was 49.2% in ‘tumor nodules’. Frozen section could be used more liberally for these lesions to aid clinical decisions. A large-scale study involving pictorial depiction of different morphological appearances and correlation with pathological findings is indicated.
AB - Background: The PRECINCT (Pattern of peritoneal dissemination and REsponse to systemic Chemotherapy IN Common and uncommon peritoneal Tumors) is a prospective, multicenter, observational study. This report from phase I of PRECINCT outlines variations in recording the surgical peritoneal cancer index (sPCI) at experienced peritoneal malignancy centers and the incidence of pathologically confirmed disease in morphologically different peritoneal lesions (PL). Methods: The sPCI was recorded in a prespecified format that included the morphological appearance of PL. Six prespecified morphological terms were provided. The surgical and pathological findings were compared. Results: From September 2020 to December 2021, 707 patients were enrolled at 10 centers. The morphological details are routinely recorded at two centers, structure bearing the largest nodule, and exact size of the largest tumor deposit in each region at four centers each. The most common morphological terms used were normal peritoneum in 3091 (45.3%), tumor nodules in 2607 (38.2%) and confluent disease in 786 (11.5%) regions. The incidence of pathologically confirmed disease was significantly higher in ‘tumor nodules’ with a lesion score of 2/3 compared with a lesion score of 1 (63.1% vs. 31.5%; p < 0.001). In patients receiving neoadjuvant chemotherapy, the incidence of pathologically confirmed disease did not differ significantly from those undergoing upfront surgery [751 (47.7%) and 532 (51.4%) respectively; p = 0.069]. Conclusions: The sPCI was recorded with heterogeneity at different centers. The incidence of pathologically confirmed disease was 49.2% in ‘tumor nodules’. Frozen section could be used more liberally for these lesions to aid clinical decisions. A large-scale study involving pictorial depiction of different morphological appearances and correlation with pathological findings is indicated.
KW - Cytoreductive surgery
KW - Morphology of peritoneal lesions
KW - Peritoneal cancer index
KW - Peritoneal metastases
KW - Peritoneal surface malignancy
KW - Surgical PCI
UR - https://www.scopus.com/pages/publications/85202037320
U2 - 10.1245/s10434-024-16035-9
DO - 10.1245/s10434-024-16035-9
M3 - Article
AN - SCOPUS:85202037320
SN - 1068-9265
VL - 31
SP - 8560
EP - 8571
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 13
ER -